tiprankstipranks
Trending News
More News >

Arvinas R&D President Ian Taylor Resigns

Story Highlights
Arvinas R&D President Ian Taylor Resigns

Confident Investing Starts Here:

Arvinas Holding Company ( (ARVN) ) just unveiled an announcement.

On June 4, 2025, Ian Taylor, Ph.D., President of Research and Development at Arvinas, Inc., announced his resignation effective June 6, 2025, to retire. Despite stepping down, Dr. Taylor will continue to contribute to the company by entering a Consulting Agreement to provide advisory services for one year and will remain as chair of the Scientific Advisory Board.

The most recent analyst rating on (ARVN) stock is a Buy with a $87.00 price target. To see the full list of analyst forecasts on Arvinas Holding Company stock, see the ARVN Stock Forecast page.

Spark’s Take on ARVN Stock

According to Spark, TipRanks’ AI Analyst, ARVN is a Neutral.

The overall score reflects strong strategic developments in clinical trials and cost-saving initiatives, but is tempered by ongoing profitability challenges and negative cash flows. Technical indicators and valuation also suggest risks.

To see Spark’s full report on ARVN stock, click here.

More about Arvinas Holding Company

Average Trading Volume: 3,089,836

Technical Sentiment Signal: Sell

Current Market Cap: $507.3M

For a thorough assessment of ARVN stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1